Form 4: Teladoc Health Director Jason Eric Evans Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Director Jason Eric Evans reports acquisition of 17,467 restricted stock units in Teladoc Health, Inc.
Summary
- On May 23, 2024, Jason Eric Evans, a director of Teladoc Health, Inc., acquired 17,467 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of TDOC common stock.
- The RSUs vest in full on the earlier of May 23, 2025, or the day before the issuer's 2025 annual meeting of stockholders.
- Vested shares will be delivered under specific conditions, including separation of service, change of control, or death.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally a good sign, indicating confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of restricted stock units by a director signals confidence in the company's future performance.
Future Outlook
The vesting of the RSUs is contingent upon continued service or specific events like a change of control or death, aligning the director's interests with the long-term performance of the company.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects part of the company's compensation strategy to align executive interests with shareholder value.
Comparison to Industry Standards
- Granting restricted stock units to directors is a common practice among publicly traded companies to incentivize performance and align their interests with shareholders.
- Companies like Amwell (AMWL) and Livongo (now part of Teladoc) have used similar equity-based compensation strategies.
- The vesting schedule of one year is fairly standard, although some companies may use longer vesting periods.
Stakeholder Impact
- The acquisition of RSUs by a director can positively influence shareholder sentiment, as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Acquisition of restricted stock units. |
| 05/23/2025 | Vesting date of restricted stock units (or earlier if the 2025 annual meeting is before this date). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.